During Nov.7 to 27, the company successfully held 14 on-site office meetings for 2014. The company president Li Boliang and the related functional department leaders all attended the meeting.
This month, Huadong Medicine awarded “ top 10 listed pharmaceutical and medical companies”; At the same time, Chen Bo, secretary of the board of directors of the company, won the award of "gold secretary of the board of directors in the first ranking list of Chinese listed companies".
Huadong Medicine Co.,Ltd., with years of good performance, sound corporate operation and constantly improving corporate governance, continues to win the award of "top 100 Chinese mainboard-listed companies in 2013". At the same time, Chen Bo, secretary of the board of directors, has won the "top 100 secretary of the board of directors" award for three consecutive years.
During Oct.13 to 14, 2014, Sino-US Huadong fourth quarter marketing work conference held smoothly. The meeting summarized the marketing work in the first three quarters. In the third quarter, the company continued to maintain steady development. From January to September, sales revenue increased by 30% year-on-year and profit increased by 37% year-on-year. In the current grim situation of the pharmaceutical industry, such performance is not easy.
On Oct.17th, Huadong Medicine ( Business ) held fourth quarter executive meeting. At the meeting, business general manager wan lingling delivered the keynote speech of "sincere cooperation to establish a new business model". For the fourth quarter, Wan put forward a number of important tasks, including "completing the acquisition of Longquan pharmaceutical, sorting out the completion of the annual agreement signing of large varieties".
To further stimulate the work of outstanding performance for the enterprise to make outstanding contributions to the grass-roots staff, and set a corporate example, Huadong Medicine Co.,Ltd carried out 2014 third quarter advanced evaluation commendation work.
During August 22 to 24, 2014, "The sixth China's top 20 most competitive pharmaceutical listed companies and the top 10 most invested pharmaceutical listed companies of 2014" was announced. Huadong Medicine awarded 2014 “ top 10 listed pharmaceutical companies with the most investment value”
In order to strengthen the construction of the company's internal training system, the company held the semi-annual review conference of 2014 teachers' day activity and internal trainer project on the afternoon of September 10. Lv Liang, deputy general manager of the joint stock company, attended the meeting with Shao Lingmin, deputy secretary of the party committee.
On Sep.13th, Huadong Medicine eighth staff ( funny) sports game was held smoothly at North City Sports Center, Hangzhou. There are more than 1000 Huadong athletes participated in this activity. The theme of the games is "I participate, I am healthy and I am happy". The aim of the games is to create a "big family" in east China that is cooperative, united, harmonious and progressive through such activities.
On Sep.19, in response to the company's "going out" to advanced enterprise learning activities, under the leadership of Shao Lingmin, deputy secretary of the party committee of the joint stock company and President of the trade union, 33 workers from Huadong Medicine trade union and part-time union cadres came to Dong'e donkey hide gelatin of Shandong province to visit and study.
In order to expand the national market in a more comprehensive and in-depth way, carry out fine marketing and fine management, Sino-Huadong is committed to the marketing organization and the expansion of specialized sales teams.
On August, 2014, Huadong Medicine “ key technology of acarbose raw material and preparation industrialization” project won the second prize of national science and technology progress award. This project is the second national science and technology progress award of the company after the 2005 cyclosporin project won the second prize of national science and technology progress award.